Etanercept in graft-versus-host disease

被引：24

作者：

Andolina, M ^{[1
]}

Rabusin, M ^{[1
]}

Maximova, N ^{[1
]}

Di Leo, G ^{[1
]}

机构：

[1] Inst Maternal & Child Hlth, Bone Marrow Unit, Trieste, Italy

来源：

BONE MARROW TRANSPLANTATION | 2000年 / 26卷 / 08期

关键词：

D O I：

10.1038/sj.bmt.1702638

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：929 / 929

页数：1

共 6 条

[1] Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease [J].

Brown, GR ;

Lindberg, G ;

Meddings, J ;

Silva, M ;

Beutler, B ;

Thiele, D .

GASTROENTEROLOGY, 1999, 116 (03) :593-601

[2] Differential effects of anti-Fas ligand and anti-tumor necrosis factor α antibodies on acute graft-versus-host disease pathologies [J].

Hattori, K ;

Hirano, T ;

Miyajima, H ;

Yamakawa, N ;

Tateno, M ;

Oshimi, K ;

Kayagaki, N ;

Yagita, H ;

Okumura, K .

BLOOD, 1998, 91 (11) :4051-4055

[3] Etanercept in children with polyarticular juvenile rheumatoid arthritis. [J].

Lovell, DJ ;

Giannini, EH ;

Reiff, A ;

Cawkwell, GD ;

Silverman, ED ;

Nocton, JJ ;

Stein, LD ;

Gedalia, A ;

Ilowite, NT ;

Wallace, CA ;

Whitmore, J ;

Finck, BK .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (11) :763-769

[4]

MOHLER KM, 1993, J IMMUNOL, V151, P1548

[5] TUMOR-NECROSIS-FACTOR CACHECTIN IS AN EFFECTOR OF SKIN AND GUT LESIONS OF THE ACUTE PHASE OF GRAFT-VS-HOST DISEASE [J].

PIGUET, PF ;

GRAU, GE ;

ALLET, B ;

VASSALLI, P .

JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (05) :1280-1289

[6] GRAFT-VERSUS-HOST DISEASE - NEW DIRECTIONS FOR A PERSISTENT PROBLEM [J].

VOGELSANG, GB ;

HESS, AD .

BLOOD, 1994, 84 (07) :2061-2067

← 1 →